FDA.reportPublic FDA data

NDC 42023-221-01 - ERTAPENEM

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
42023-221
Requested NDC
42023-221-01
Package NDCs from labels
42023-221-89, 42023-221-85, 42023-221-01, 42023-221-10
Manufacturer
ENDO USA, Inc. | Merck Sharp & Dohme LLC
Effective date
2026-03-02
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ERTAPENEM - ENDO USA, Inc. | Merck Sharp & Dohme LLCENDO USA, Inc. | Merck Sharp & Dohme LLC2026-03-02HUMAN PRESCRIPTION DRUG LABEL
ERTAPENEM - ENDO USA, Inc. | Merck Sharp & Dohme LLCENDO USA, Inc. | Merck Sharp & Dohme LLC2026-03-02HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42023-221-01ERTAPENEM1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,113
42023-221-10ERTAPENEM10 in 1 PACKAGEINJECTION, POWDER, LYOPHILIZED,1013
42023-221-85ERTAPENEM10 in 1 PACKAGEINJECTION, POWDER, LYOPHILIZED,1013
42023-221-89ERTAPENEM1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,113

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42023-221ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.]10Current NDC, Legacy NDC, 2 package rows20240716_657855f2-7c92-4aa8-9c3d-51d08e56a09a.zip
42023-221ERTAPENEM (ERTAPENEM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.]9Current NDC, Legacy NDC, 2 package rows20240716_41304b1d-7db4-468a-ab1d-04e56fb50de4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42023-221-01EA - Each42023-221ab48327d-4a9d-49ae-93cb-36b2e50be6f212018-08-13
42023-221-10EA - Each42023-2215bce14c2-8926-4eb4-a8cc-2bba14d9ebd912018-08-13
42023-221-85EA - Each42023-221cca54412-b1b8-4749-9c80-0c30149b3ec612018-12-13
42023-221-89EA - Each42023-221014f44b1-2664-42fc-bdd2-c33f5769861b12018-12-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 12 · 222 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alka-Seltzer HeartburnANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED)Bayer HealthCare LLC.55158e50-0327-2043-e054-00144ff8d46c2025-12-04WarningsExact identifier
unii: 8MDF5V39QO
Alka-Seltzer Extra StrengthANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRINBayer HealthCare LLC.49b73bd5-6465-05eb-e054-00144ff88e882025-12-04WarningsExact identifier
unii: 8MDF5V39QO
Alka-Seltzer GoldALKA-SELTZER GOLDBayer HealthCare LLC.0824bedb-413b-2fa0-e054-00144ff88e882025-12-04WarningsExact identifier
unii: 8MDF5V39QO
Alka-Seltzer OriginalANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATEBayer HealthCare LLC.5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc2025-12-04WarningsExact identifier
unii: 8MDF5V39QO
OMEPRAZOLE AND SODIUM BICARBONATEOMEPRAZOLE AND SODIUM BICARBONATEAurohealth LLC88ad2e92-2228-49b2-bcee-1770fd30cb142025-12-04WarningsExact identifier
unii: 8MDF5V39QO
BM Sodium bicarbonate (Nat Bicarb)SODIUM BICARBONATEBM Private Limited38044eae-7237-6add-e063-6294a90a827b2025-12-02WarningsExact identifier
unii: 8MDF5V39QO
Omeprazole and Sodium BicarbonateOMEPRAZOLE AND SODIUM BICARBONATEAjanta Pharma USA Inc.bd84ca00-6352-4cb3-bce2-05f4a5005a942025-11-30Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
Sodium BicarbonateSODIUM BICARBONATECivicaa10fdfbc-94a0-49ab-b26c-de1df042bc892025-11-24Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
SODIUM BICARBONATESODIUM BICARBONATEGlenmark Pharmaceuticals Inc., USAf38d0dfc-9bcc-4224-a202-885c9ad0beae2025-11-20Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
Itch Eraser SensitiveSODIUM BICARBONATETender Corporation d/b/a Adventure Ready Brands2250525a-45c2-42ea-e063-6394a90ac0012025-11-18WarningsExact identifier
unii: 8MDF5V39QO
After Bite KidsSODIUM BICARBONATETender Corporation d/b/a Adventure Ready Brands226c1420-d771-204f-e063-6294a90af9f62025-11-18WarningsExact identifier
unii: 8MDF5V39QO
Alka-Seltzer OriginalANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATER J General Corporationdbb0d067-71f0-45e4-bc98-548cf4a90b3a2025-11-17WarningsExact identifier
unii: 8MDF5V39QO
After Bite X TechSODIUM BICARBONATEAdventure Ready Brandse9e49ab4-3e1f-9fd4-e053-2a95a90a775a2025-11-17WarningsExact identifier
unii: 8MDF5V39QO
QUABIC-100HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTIONAqua Medica, S.A. de C.V.1484a825-40c6-a9c9-e063-6294a90a9ca42025-11-10WarningsExact identifier
unii: 8MDF5V39QO
GURUNANDA NASAL SALINENASAL WASHGURUNANDA LLC27dbf0bf-c273-2108-e063-6394a90a0a092025-11-10WarningsExact identifier
unii: 8MDF5V39QO
QUABIC-100HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTIONAqua Medica, S.A. de C.V.28152c9f-b15c-3707-e063-6394a90a70e92025-11-10WarningsExact identifier
unii: 8MDF5V39QO
QUABIC-300HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTIONAqua Medica, S.A. de C.V.c3cd7f0f-8d70-23af-e053-2a95a90a569b2025-11-10WarningsExact identifier
unii: 8MDF5V39QO
SODIUM BICARBONATESODIUM BICARBONATEHenry Schein, Inc.da484a2f-154f-48b4-8467-7a86729204c32025-11-07Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
Sodium BicarbonateSODIUM BICARBONATEHospira, Inc.ea20a5eb-641e-48cd-bcfa-74c04c45dfda2025-11-06Warnings, Adverse reactionsExact identifier
unii: 8MDF5V39QO
CEO-TWOLAXATIVEBeutlich Pharmaceuticals, LLC08670636-5795-4db0-e063-6294a90afa4b2025-11-05WarningsExact identifier
unii: 8MDF5V39QO

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.